Correlation Between Geron and Hemogenyx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Geron and Hemogenyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Geron and Hemogenyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Geron and Hemogenyx Pharmaceuticals Plc, you can compare the effects of market volatilities on Geron and Hemogenyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Geron with a short position of Hemogenyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Geron and Hemogenyx Pharmaceuticals.
Diversification Opportunities for Geron and Hemogenyx Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Geron and Hemogenyx is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Geron and Hemogenyx Pharmaceuticals Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hemogenyx Pharmaceuticals and Geron is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Geron are associated (or correlated) with Hemogenyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hemogenyx Pharmaceuticals has no effect on the direction of Geron i.e., Geron and Hemogenyx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Geron and Hemogenyx Pharmaceuticals
Given the investment horizon of 90 days Geron is expected to generate 2.41 times less return on investment than Hemogenyx Pharmaceuticals. But when comparing it to its historical volatility, Geron is 3.24 times less risky than Hemogenyx Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Hemogenyx Pharmaceuticals Plc is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 1.41 in Hemogenyx Pharmaceuticals Plc on September 3, 2024 and sell it today you would lose (1.10) from holding Hemogenyx Pharmaceuticals Plc or give up 78.01% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Geron vs. Hemogenyx Pharmaceuticals Plc
Performance |
| Timeline |
| Geron |
| Hemogenyx Pharmaceuticals |
Geron and Hemogenyx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Geron and Hemogenyx Pharmaceuticals
The main advantage of trading using opposite Geron and Hemogenyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Geron position performs unexpectedly, Hemogenyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hemogenyx Pharmaceuticals will offset losses from the drop in Hemogenyx Pharmaceuticals' long position.| Geron vs. Viking Therapeutics | Geron vs. TG Therapeutics | Geron vs. X4 Pharmaceuticals | Geron vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |